Log in

HUTCHISON CHINA/S Stock Price, News & Analysis (NASDAQ:HCM)

$19.52
+0.61 (+3.23 %)
(As of 10/17/2019 06:37 AM ET)
Today's Range
$18.82
Now: $19.52
$19.74
50-Day Range
$17.13
MA: $19.77
$21.85
52-Week Range
$16.47
Now: $19.52
$39.68
Volume143,378 shs
Average Volume145,062 shs
Market Capitalization$2.60 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.64
Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HCM
CUSIPN/A
Phone852-2128-1188

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.11 million
Book Value$3.10 per share

Profitability

Miscellaneous

Employees714
Market Cap$2.60 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive HCM News and Ratings via Email

Sign-up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.


HUTCHISON CHINA/S (NASDAQ:HCM) Frequently Asked Questions

What is HUTCHISON CHINA/S's stock symbol?

HUTCHISON CHINA/S trades on the NASDAQ under the ticker symbol "HCM."

What price target have analysts set for HCM?

3 Wall Street analysts have issued twelve-month target prices for HUTCHISON CHINA/S's shares. Their predictions range from $26.82 to $26.82. On average, they anticipate HUTCHISON CHINA/S's stock price to reach $26.82 in the next year. This suggests a possible upside of 37.4% from the stock's current price. View Analyst Price Targets for HUTCHISON CHINA/S.

What is the consensus analysts' recommendation for HUTCHISON CHINA/S?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HUTCHISON CHINA/S in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HUTCHISON CHINA/S.

Has HUTCHISON CHINA/S been receiving favorable news coverage?

Media headlines about HCM stock have trended very negative on Thursday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HUTCHISON CHINA/S earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for HUTCHISON CHINA/S.

Who are some of HUTCHISON CHINA/S's key competitors?

What other stocks do shareholders of HUTCHISON CHINA/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HUTCHISON CHINA/S investors own include Telford Homes (TEF), Premier Oil (PMO), GW Pharmaceuticals PLC- (GWPH), Exelixis (EXEL), Crispr Therapeutics (CRSP), Alibaba Group (BABA), Madrigal Pharmaceuticals (MDGL), Spark Therapeutics (ONCE), AbbVie (ABBV) and Johnson & Johnson (JNJ).

Who are HUTCHISON CHINA/S's key executives?

HUTCHISON CHINA/S's management team includes the folowing people:
  • Mr. Chi Keung To B.Sc., M.B.A., BSc, ACGI, MBA, Exec. Chairman (Age 67)
  • Mr. Christian Hogg B.Sc., M.B.A., BSc, MBA, CEO & Exec. Director (Age 53)
  • Mr. Johnny Cheng C.A., BEc, CA, CFO & Exec. Director (Age 52)
  • Dr. Weiguo Su B.Sc., Ph.D., Chief Scientific Officer, Exec. VP & Exec. Director (Age 62)
  • Ms. Edith Shih B.S., M.A., BSE, MA, EdM, Solicitor, FCIS, FCS(PE), Company Sec. & Non-Exec. Director (Age 67)

When did HUTCHISON CHINA/S IPO?

(HCM) raised $100 million in an initial public offering (IPO) on Thursday, March 17th 2016. The company issued 6,100,000 shares at $16.33 per share. BofA Merrill Lynch and Deutsche Bank Securities acted as the underwriters for the IPO and Stifel, Canaccord Genuity, Panmure Gordon and CITIC CLSA were co-managers.

How do I buy shares of HUTCHISON CHINA/S?

Shares of HCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is HUTCHISON CHINA/S's stock price today?

One share of HCM stock can currently be purchased for approximately $19.52.

How big of a company is HUTCHISON CHINA/S?

HUTCHISON CHINA/S has a market capitalization of $2.60 billion and generates $214.11 million in revenue each year. The company earns $-74,810,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. HUTCHISON CHINA/S employs 714 workers across the globe.View Additional Information About HUTCHISON CHINA/S.

What is HUTCHISON CHINA/S's official website?

The official website for HUTCHISON CHINA/S is http://www.chi-med.com/.

How can I contact HUTCHISON CHINA/S?

HUTCHISON CHINA/S's mailing address is 48TH FLOOR CHEUNG KONG CENTER 2 QUEEN`S ROAD CENTRAL, HONG KONG K3, . The company can be reached via phone at 852-2128-1188 or via email at [email protected]


MarketBeat Community Rating for HUTCHISON CHINA/S (NASDAQ HCM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  243 (Vote Outperform)
Underperform Votes:  211 (Vote Underperform)
Total Votes:  454
MarketBeat's community ratings are surveys of what our community members think about HUTCHISON CHINA/S and other stocks. Vote "Outperform" if you believe HCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: What is a blue-chip stock?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel